ObsEva appoints Annette Clancy as Chair of its Board of Directors
– SWITZERLAND, Geneva – ObsEva SA ( SIX: OBSN | NASDAQ: OBSV), a biopharmaceutical company developing and commercializing novel therapies for women’s health, today announced the appointment of Annette Clancy as Chair of the Board of Directors on May 18, 2022, succeeding Dr.…